tDCS and Inhibitory Control in PTSD
Key facts
- Who runs it
- Gopalkumar Rakesh
- Where
- Lexington, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 38 people enrolled
- Started
- 27 Oct 2023
- Ended
- 4 Dec 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- tDCS
- Record updated
- 16 January 2025
Who can take part
- Age
- 18 years to 55 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Ability to provide informed consent
- Ability and willingness to perform procedures
- Age 18-55
- Female sex
- Meet diagnostic criteria for past-month probable IPV-related PTSD
- Medication free or stable (≥4 weeks) medication(s)
Who cannot take part
- Daily use of psychostimulant medication
- Unstable medical, psychiatric, or neurological condition that may necessitate urgent treatment
- History of psychosis, mania, major neurological disorder, significant head trauma, or epilepsy
- Daily use of medications that significantly lower seizure threshold
- History of seizures
- Moderate severity substance-use disorder
- Contraindications for tDCS
- Current suicidal intent
- Current pregnancy
Where in United States
- University of KentuckyLexington, United States
About the trial
What the trial wants to find out
Large samples (~2,000/yr) of adult undergraduate students at a large southern university will be pre-screened via the University of Kentucky SONA System (IRB#43626) to identify and recruit adult female participants who report a history of IPV and probable PTSD to participate in a one-day lab study. After completing an IRB-approved informed consent, participants will complete a brief psychiatric diagnostic interview and a battery of questionnaires. They will then complete three blocks of the Stop Signal Task (SST). Participants will be randomized (double-blind, stratified by PTSD diagnosis and psychotropic medication use) to receive 15-min of active or sham multifocal tDCS targeting the rIFG. tDCS will be delivered offline for 11.5-mins after block 1 of the SST and online for 3.5-mins during block 2 of the SST. Sham stimulation will be identical to active tDCS, but electrical current will only be ramped in/out at the beginning and end of the 15-mins. The third block of the SST will be completed after tDCS. Lastly, participants will complete a pictorial trauma-related symptom provocation task. Participants will be compensated with course credit.
The 2 groups in the trial
- Active tDCSExisting treatment, for comparison
Current will be ramped in/out for 15 seconds at the beginning and end of a 15-minute period and a constant current will be delivered for the 15-minutes between ramping
Treatment: tDCS
- Shame tDCSSham treatment, for comparison
Current will be ramped in/out for 15 seconds at the beginning and end of a 15-minute period during which no stimulation will be delivered.
Treatment: tDCS
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluating the Impact of Transcranial Direct Current Stimulation on Inhibitory Control in PTSD
- Record updated
- 16 January 2025